{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:28:34Z","timestamp":1793381314995,"version":"4.5.0"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>\n                    The metabolic disease hyperuricemia (HUA) is caused by presence of excessive serum uric acid (UA), which leads to an increased risk of chronic kidney disease and gout. As a widely used traditional Chinese medicine, Euodiae fructus (ER) has strong anti-inflammatory and analgesic effects, however, its therapeutic effects on HUA and gout have not been investigated. To investigate the potential effects and underlying mechanisms, the effect of ER on proinflammatory cytokines and NLRP3 inflammasome activation was studied in mouse bone marrow macrophages. Moreover, a mouse model of HUA and gouty arthritis was established by coadministration of potassium oxonate (PO) and monosodium urate crystals to mice fed a high-fat diet (HFD) for 37 consecutive days. Oral administration of ER aqueous extract was given 1\u00a0hour later after the injection of PO for 10 days. Our study showed that ER is a powerful NLRP3 inhibitor in mouse macrophages. Most importantly, ER (0.75\u00a0g\/kg) treatment substantially decreased the ankle joint thickness ratio, serum UA, creatinine and blood urea nitrogen levels (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.05). Additionally, ER (0.75\u00a0g\/kg) dramatically reversed the increases in renal urate transporter 1 (URAT1) and glucose transporter 9 (GLUT9) as well as the decreases in organic anion transporter 1 (OAT1) and ATP binding cassette subfamily G member 2 (ABCG2) levels (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.05). Moreover, ER (0.75\u00a0g\/kg) markedly ameliorated the production of the serum inflammatory cytokines IL-1\u03b2 and TNF-\u03b1 (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.01), and improved the activation of NLRP3 inflammasome signaling in the kidneys. Taken together, these data indicate that ER, a powerful and specific NLRP3 inhibitor, has multiple anti-HUA, anti-gout and anti-inflammatory effects. Our investigation is designed to experimentally support the conventional use of ER-containing classical herbal formulas in the treatment of HUA-related disorders and may add a new dimension to the clinical application of ER.\n                  <\/jats:p>","DOI":"10.3389\/fphar.2024.1296075","type":"journal-article","created":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:39:54Z","timestamp":1713487194000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-inflammatory and uric acid lowering effects of Euodiae fructus on hyperuricemia and gout mice"],"prefix":"10.3389","volume":"15","author":[{"given":"Zhilei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyuan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,4,19]]},"reference":[{"key":"B1","first-page":"235","article-title":"Antinociceptive activity of aqueous and alcohol extract of evodia rutaecarpa","volume":"76","author":"Cai","year":"2014","journal-title":"Indian J. Pharm. Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1007\/s00210-023-02654-8","article-title":"Effects of evodiamine on ROS\/TXNIP\/NLRP3 pathway against gouty arthritis","volume":"397","author":"Cheng","year":"2023","journal-title":"Naunyn Schmiedeb. Arch. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13020-020-0297-y","article-title":"Chinese herbal medicine for gout: a review of the clinical evidence and pharmacological mechanisms","volume":"15","author":"Chi","year":"2020","journal-title":"Chin. Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.ejim.2022.04.022","article-title":"Uric acid in metabolic syndrome: does uric acid have a definitive role?","volume":"103","author":"Copur","year":"2022","journal-title":"Eur. J. Intern Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/21655979.2021.1999554","article-title":"Dehydroevodiamine suppresses inflammatory responses in adjuvant-induced arthritis rats and human fibroblast-like synoviocytes","volume":"13","author":"Dai","year":"2022","journal-title":"Bioengineered"},{"key":"B6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41572-019-0115-y","article-title":"Gout","volume":"5","author":"Dalbeth","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0140-6736(21)00569-9","article-title":"Gout","volume":"397","author":"Dalbeth","year":"2021","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","first-page":"101723","DOI":"10.1016\/j.berh.2021.101723","article-title":"Role of diet in hyperuricemia and gout","volume":"35","author":"Danve","year":"2021","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"573870","DOI":"10.3389\/fphar.2020.573870","article-title":"Evodiamine attenuates experimental colitis injury via activating autophagy and inhibiting NLRP3 inflammasome assembly","volume":"11","author":"Ding","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e00817","DOI":"10.1002\/prp2.817","article-title":"Kidney damage from nonsteroidal anti-inflammatory drugs-Myth or truth? Review of selected literature","volume":"9","author":"Dro\u017cd\u017cal","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"key":"B12","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.3390\/molecules27196213","article-title":"A selective review and virtual screening analysis of natural product inhibitors of the NLRP3 inflammasome","volume":"27","author":"El-Sayed","year":"2022","journal-title":"Molecules"},{"key":"B13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.3109\/15563650.2010.495348","article-title":"Colchicine poisoning: the dark side of an ancient drug","volume":"48","author":"Finkelstein","year":"2010","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1040154","DOI":"10.3389\/fphar.2022.1040154","article-title":"The pharmacokinetics profiles, pharmacological properties, and toxicological risks of dehydroevodiamine: a review","volume":"13","author":"Fu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","article-title":"NLRP3 inflammasome activation and cell death","volume":"18","author":"Huang","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s11892-023-01506-2","article-title":"Prevalence of diabetes in patients with hyperuricemia and gout: a systematic review and meta-analysis","volume":"23","author":"Jiang","year":"2023","journal-title":"Curr. Diab Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"3064","DOI":"10.1248\/cpb.39.3064","article-title":"Pharmacological properties of galenical preparation. XV. Pharmacokinetics study of evocarpine and its metabolite in rats","volume":"39","author":"Kano","year":"1991","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"12394","DOI":"10.3390\/ijms222212394","article-title":"Uric acid in inflammation and the pathogenesis of atherosclerosis","volume":"22","author":"Kimura","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"8698232","DOI":"10.1155\/2021\/8698232","article-title":"Advances in experimental and clinical research of the gouty arthritis treatment with traditional Chinese medicine","volume":"2021","author":"Liang","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1749-8546-6-6","article-title":"Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components","volume":"6","author":"Liao","year":"2011","journal-title":"Chin. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1199799","DOI":"10.3389\/fchem.2023.1199799","article-title":"Promising derivatives of rutaecarpine with diverse pharmacological activities","volume":"11","author":"Li","year":"2023","journal-title":"Front. Chem."},{"key":"B22","first-page":"3167","article-title":"Update on the epidemiology, genetics, and therapeutic options of hyperuricemia","volume":"12","author":"Li","year":"","journal-title":"Am. J. Transl. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"113231","DOI":"10.1016\/j.jep.2020.113231","article-title":"Traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the fruit of Tetradium ruticarpum: a review","volume":"263","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"153180","DOI":"10.1016\/j.phymed.2020.153180","article-title":"Evodiamine and rutaecarpine from Tetradium ruticarpum in the treatment of liver diseases","volume":"68","author":"Li","year":"","journal-title":"Phytomedicine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1096\/fj.201900903RRR","article-title":"Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport","volume":"34","author":"Luo","year":"2020","journal-title":"Faseb J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"B27","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/jssc.201000698","article-title":"Quantification of flavonoid glycosides in an aqueous extract from the traditional Mongolian medicinal plant Dianthus versicolor FISCH","volume":"34","author":"Obmann","year":"2011","journal-title":"J. Sep. Sci."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.3390\/ijms20122876","article-title":"Phytochemicals as novel therapeutic strategies for NLRP3 inflammasome-related neurological, metabolic, and inflammatory diseases","volume":"20","author":"Pellegrini","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.jare.2017.04.008","article-title":"Gout: an old disease in new perspective - a review","volume":"8","author":"Ragab","year":"2017","journal-title":"J. Adv. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.biopha.2018.12.033","article-title":"Evodiamine prevents dextran sulfate sodium-induced murine experimental colitis via the regulation of NF-\u03baB and NLRP3 inflammasome","volume":"110","author":"Shen","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B31","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0163-7258(94)90010-8","article-title":"Comparative toxicity of non-steroidal anti-inflammatory agents","volume":"62","author":"Singh","year":"1994","journal-title":"Pharmacol. Ther."},{"key":"B32","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/j.bbadis.2018.03.009","article-title":"Benzbromarone aggravates hepatic steatosis in obese individuals","volume":"1864","author":"Sun","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"B34","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.phrs.2018.12.019","article-title":"Rutaecarpine: a promising cardiovascular protective alkaloid from Evodia rutaecarpa (Wu Zhu Yu)","volume":"141","author":"Tian","year":"2019","journal-title":"Pharmacol. Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"225","DOI":"10.2165\/11533190-000000000-00000","article-title":"Allopurinol in dermatology","volume":"11","author":"Tsai","year":"2010","journal-title":"Am. J. Clin. Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"104978","DOI":"10.1016\/j.phrs.2020.104978","article-title":"Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production","volume":"159","author":"Wang","year":"","journal-title":"Pharmacol. Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"935723","DOI":"10.3389\/fcimb.2022.935723","article-title":"Gut microbiota remodeling: a promising therapeutic strategy to confront hyperuricemia and gout","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"115031","DOI":"10.1016\/j.ejmech.2022.115031","article-title":"Natural product evodiamine-inspired medicinal chemistry: anticancer activity, structural optimization and structure-activity relationship","volume":"247","author":"Wang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"B39","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.apsb.2019.02.003","article-title":"Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome","volume":"9","author":"Wang","year":"","journal-title":"Acta Pharm. Sin. B"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.apsb.2020.03.006","article-title":"Icariside \u2161, a main compound in Epimedii Folium, induces idiosyncratic hepatotoxicity by enhancing NLRP3 inflammasome activation","volume":"10","author":"Wang","year":"","journal-title":"Acta Pharm. Sin. B"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1007\/s00204-019-02606-3","article-title":"Carbamazepine promotes specific stimuli-induced NLRP3 inflammasome activation and causes idiosyncratic liver injury in mice","volume":"93","author":"Wang","year":"","journal-title":"Arch. Toxicol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"153619","DOI":"10.1016\/j.phymed.2021.153619","article-title":"Therapeutic effects and potential mechanism of dehydroevodiamine on N-methyl-N'-nitro-N-nitrosoguanidine-induced chronic atrophic gastritis","volume":"91","author":"Wen","year":"2021","journal-title":"Phytomedicine"},{"key":"B43","doi-asserted-by":"publisher","first-page":"113377","DOI":"10.1016\/j.envres.2022.113377","article-title":"Environmental factors and risk of gout","volume":"212","author":"Wu","year":"2022","journal-title":"Environ. Res."},{"key":"B44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.bmc.2010.10.060","article-title":"Design, synthesis and antimycobacterial activities of 1-methyl-2-alkenyl-4(1H)-quinolones","volume":"19","author":"Wube","year":"2011","journal-title":"Bioorg Med. Chem."},{"key":"B45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jdermsci.2005.12.009","article-title":"Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine","volume":"42","author":"Yarosh","year":"2006","journal-title":"J. Dermatol Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e15214","DOI":"10.1097\/MD.0000000000015214","article-title":"Benzbromarone as a possible cause of acute kidney injury in patients with urolithiasis: two case reports","volume":"98","author":"Ye","year":"2019","journal-title":"Med. Baltim."},{"key":"B47","doi-asserted-by":"publisher","first-page":"14474","DOI":"10.1021\/acs.jmedchem.3c01710","article-title":"Agents for the treatment of gout: current advances and future perspectives","volume":"66","author":"Zeng","year":"2023","journal-title":"J. Med. Chem."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1744806920902563","DOI":"10.1177\/1744806920902563","article-title":"Evodiamine reduced peripheral hypersensitivity on the mouse with nerve injury or inflammation","volume":"16","author":"Zhang","year":"2020","journal-title":"Mol. Pain"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1109938","DOI":"10.3389\/fimmu.2022.1109938","article-title":"The mechanism of NLRP3 inflammasome activation and its pharmacological inhibitors","volume":"13","author":"Zhan","year":"2022","journal-title":"Front. Immunol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1296075\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:39:58Z","timestamp":1713487198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2024.1296075\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,19]]},"references-count":49,"alternative-id":["10.3389\/fphar.2024.1296075"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2024.1296075","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,19]]},"article-number":"1296075"}}